Wait for it–Shire could finally announce $32.5B Baxalta deal by Monday

Carly Helfand

Shire's months-long pursuit of be coming to a close? That's the word from Reuters, which says the Dublin drugmaker is preparing to its acquisition–valued at about $ 32.5 billion–as early as

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS